Antibiotic resistance threats in the United States: Stepping back from the brink

American Family Physician

Volumn 89, Issue 12, 2014, Pages 938-

  Solomon, Steven L ^a   Oliver, Kristen B ^a  

^a CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEPHALOSPORIN; INFLUENZA VACCINE; PNEUMOCOCCUS VACCINE;

ACINETOBACTER; ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; CAMPYLOBACTER; CANDIDIASIS; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; CLOSTRIDIUM DIFFICILE INFECTION; DRUG RESISTANT TUBERCULOSIS; DRUG USE; EDITORIAL; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; HUMAN; INFECTION CONTROL; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; NEISSERIA GONORRHOEAE; PRESCRIPTION; PSEUDOMONAS AERUGINOSA; PUBLIC HEALTH; SALMONELLA; SHIGELLA; UNITED STATES; VANCOMYCIN RESISTANT ENTEROCOCCUS; VANCOMYCIN RESISTANT STAPHYLOCOCCUS AUREUS; VIRAL UPPER RESPIRATORY TRACT INFECTION;

BACTERIAL INFECTIONS; CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); DRUG RESISTANCE, MICROBIAL; HUMANS; PUBLIC HEALTH; UNITED STATES;

EID: 84902477340     PISSN: 0002838X     EISSN: 15320650     Source Type: Journal    
DOI: None     Document Type: Editorial

References (29)

1. Centers for Disease Control and Prevention. Vital signs: making health care safer. Stopping C. difficile infections. March 2012. http://www. cdc. gov/VitalSigns/Hai/StoppingCdifficile/. Accessed March 27, 2014.
2. Infectious Diseases Society of America. Infections by organism: Clostridium difficile. http://www. idsociety. org//organism/#Clostridiumdifficile. Accessed March 27, 2014.
3. Centers for Disease Control and Prevention. Vital signs: making health care safer. Stop infections from lethal CRE germs now. March 2013. http://www. cdc. gov/vitalsigns/HAI/CRE/. Accessed March 27, 2014.
4. Bolan GA, Sparling PF, Wasserheit JN. The emerging threat of untreatable gonococcal infection. N Engl J Med. 2012; 366(6): 485-487.
5. Huang XZ, Chahine MA, Frye JG, et al. Molecular analysis of imipenem-resistant Acinetobacter baumannii isolated from US service members wounded in Iraq, 2003-2008. Epidemiol Infect. 2012; 140(12): 2302-2307.
6. Centers for Disease Control and Prevention. National Center for Emerging and Zoonotic Infectious Diseases. Campylobacter. http://www. cdc. gov/nczved/divisions/dfbmd/diseases/campylobacter/technical. html. Accessed March 27, 2014.
7. Niimi M, Firth NA, Cannon RD. Antifungal drug resistance of oral fungi. Odontology. 2010; 98(1): 15-25.
8. Centers for Disease Control and Prevention. Fungal diseases. Candidiasis. http://www. cdc. gov/fungal/diseases/candidiasis/index. html. Accessed March 27, 2014.
9. Cleveland AA, Farley MM, Harrison LH, et al. Changes in incidence and antifungal drug resistance in candidemia: results from population-based laboratory surveillance in Atlanta and Baltimore, 2008-2011. Clin Infect Dis. 2012; 55(10): 1352-1361.
10. Hayakawa K, Gattu S, Marchaim D, et al. Epidemiology and risk factors for isolation of Escherichia coli producing CTX-M-type extended-spectrum ß-lactamase in a large U. S. medical center. Antimicrob Agents Chemother. 2013; 57(8): 4010-4018.
11. Doi Y, Park YS, Rivera JI, et al. Community-associated extended-spectrum ß-lactamase-producing Escherichia coli infection in the United States. Clin Infect Dis. 2013; 56(5): 641-648.
12. Grabsch EA, Burrell LJ, Padiglione A, O'Keeffe JM, Ballard S, Grayson ML. Risk of environmental and healthcare worker contamination with vancomycin-resistant enterococci during outpatient procedures and hemodialysis. Infect Control Hosp Epidemiol. 2006; 27(3): 287-293.
13. Centers for Disease Control and Prevention. Healthcare-associated infections (HAIs). Vancomycin-resistant enterococii (VRE) in healthcare settings. http://www. cdc. gov/HAI/organisms/vre/vre. html. Accessed March 27, 2014.
14. Magill SS, Edwards JR, Bamberg W, et al.; Emerging Infections Program Healthcare-Associated Infections and Antimicrobial Use Prevalence Survey Team. Multistate point-prevalence survey of health care-associated infections. N Engl J Med. 2014; 370(13): 1198-1208.
15. Centers for Disease Control and Prevention. Healthcare-associated infections (HAIs). http://www. cdc. gov/HAI/organisms/Pseudomonas. html. Accessed March 27, 2014.
16. Centers for Disease Control and Prevention. Healthy swimming/recreational water. Hot tub rash (Pseudomonas dermatitis/folliculitis). http://www. cdc. gov/healthywater/swimming/rwi/illnesses/hot-tub-rash. html. Accessed March 27, 2014.
17. Centers for Disease Control and Prevention. Vital signs: making food safer to eat. Reducing contamination from the farm to the table. June 2011. http://www. cdc. gov/VitalSigns/FoodSafety/. Accessed March 27, 2014.
18. Centers for Disease Control and Prevention. Salmonella. http://www. cdc. gov/salmonella/. Accessed March 27, 2014.
19. Centers for Disease Control and Prevention. National Center for Emerging and Zoonotic Infectious Diseases. Typhoid fever. http://www. cdc. gov/nczved/divisions/dfbmd/diseases/typhoid_fever/. Accessed March 27, 2014.
20. Centers for Disease Control and Prevention. National Center for Emerging and Zoonotic Infectious Diseases. Shigellosis. http://www. cdc. gov/nczved/divisions/dfbmd/diseases/shigellosis/. Accessed March 27, 2014.
21. Centers for Disease Control and Prevention. Methicillin-resistant Staphylococcus aureus (MRSA) infections. Treating MRSA skin and soft tissue infections in outpatient settings. http://www. cdc. gov/mrsa/community/clinicians/index. html. Accessed March 27, 2014.
22. Dantes R, Mu Y, Belflower R, et al.; Emerging Infections Program-Active Bacterial Core Surveillance MRSA Surveillance Investigators. National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011. JAMA Intern Med. 2013; 173(21): 1970-1978.
23. Infectious Diseases Society of America. Infections by organism: MRSA. http://www. idsociety. org//organism/#MRSA. Accessed March 27, 2014.
24. Centers for Disease Control and Prevention. Vaccine recommendations of the ACIP. Pnuemococcal ACIP vaccine recommendations. http://www. cdc. gov/vaccines/hcp/acip-recs/vacc-specific/pneumo. html. Accessed March 27, 2014.
25. Centers for Disease Control and Prevention. Tuberculosis (TB): fact sheet. Trends in tuberculosis, 2012. http://www. cdc. gov/tb/publications/factsheets/statistics/TBTrends. htm. Accessed March 27, 2014.
26. Infectious Diseases Society of America. Infections by organism: control of tuberculosis (TB). http://www. idsociety. org//organism/#ControlofTuberculosisTB. Accessed March 27, 2014.
27. Centers for Disease Control and Prevention. Healthcare-associated infections (HAIs). http://www. cdc. gov/HAI/organisms/visa_vrsa/visa_vrsa. html. Accessed March 27, 2014.
28. Centers for Disease Control and Prevention. Group A streptococcal (GAS) disease. http://www. cdc. gov/groupAstrep/clinicians. html. Accessed May 15, 2014.
29. Centers for Disease Control and Prevention. Group B strep (GBS). http://www. cdc. gov/groupbstrep/about/index. html. Accessed March 27, 2014.